Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 416145, 6 pages
http://dx.doi.org/10.1155/2015/416145
Case Report

A Case of Type 2 Amiodarone-Induced Thyrotoxicosis That Underwent Total Thyroidectomy under High-Dose Steroid Administration

1Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
2Department of Preemptive Medicine and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan
3Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
4Department of Thoracic Visceral Organ Surgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
5Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan

Received 17 October 2014; Accepted 15 December 2014

Academic Editor: Takeshi Usui

Copyright © 2015 Koshi Hashimoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Roy, M. Talajic, P. Dorian et al., “Amiodarone to prevent recurrence of atrial fibrillation,” New England Journal of Medicine, vol. 342, no. 13, pp. 913–920, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. D. P. Zipes, E. N. Prystowsky, and J. J. Heger, “Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects,” Journal of the American College of Cardiology, vol. 3, no. 4, pp. 1059–1071, 1984. View at Publisher · View at Google Scholar · View at Scopus
  3. R. H. Rao, V. R. McCready, and G. S. Spathis, “Iodine kinetic studies during amiodarone treatment,” Journal of Clinical Endocrinology and Metabolism, vol. 62, no. 3, pp. 563–568, 1986. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Piga, A. Serra, F. Boi, M. L. Tanda, E. Martino, and S. Mariotti, “Amiodarone-induced thyrotoxicosis: a review,” Minerva Endocrinologica, vol. 33, no. 3, pp. 213–228, 2008. View at Google Scholar · View at Scopus
  5. C. B. Franzese and B. C. Stock Jr., “Amiodarone-induced thyrotoxicosis: a case for surgical management,” American Journal of Otolaryngology—Head and Neck Medicine and Surgery, vol. 23, no. 6, pp. 358–361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Martino, L. Bartalena, F. Bogazzi, and L. E. Braverman, “The effects of amiodarone on the thyroid,” Endocrine Reviews, vol. 22, no. 2, pp. 240–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Bogazzi, L. Bartalena, and E. Martino, “Approach to the patient with amiodarone-induced thyrotoxicosis,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2529–2535, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. Conen, L. Melly, C. Kaufmann et al., “Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome,” Journal of the American College of Cardiology, vol. 49, no. 24, pp. 2350–2355, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. Birkedal, J. Touliatos, T. Gaskin, and R. K. Spence, “Surgical considerations for treatment of amiodarone-induced thyrotoxicosis,” Current Surgery, vol. 58, no. 5, pp. 478–480, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Nakazawa, S.-I. Murata, T. Kondo et al., “Histopathology of the thyroid in amiodarone-induced hypothyroidism,” Pathology International, vol. 58, no. 1, pp. 55–58, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. A. Franklyn and M. D. Gammage, “Treatment of amiodarone-associated thyrotoxicosis,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 9, pp. 662–666, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. L. Bartalena, S. Brogioni, L. Grasso, F. Bogazzi, A. Burelli, and E. Martino, “Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 8, pp. 2930–2933, 1996. View at Google Scholar · View at Scopus
  13. S. G. Houghton, D. R. Farley, M. D. Brennan, J. A. Van Heerden, G. B. Thompson, and C. S. Grant, “Surgical management of amiodarone-associated thyrotoxicosis:mayo clinic experience,” World Journal of Surgery, vol. 28, no. 11, pp. 1083–1087, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. C. B. Franzese, C. Y. Fan, and B. C. Stack, “Surgical management of amiodarone-induced thyrotoxicosis,” Otolaryngology—Head and Neck Surgery, vol. 129, no. 5, pp. 565–570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Berti, G. Materazzi, F. Bogazzi, C. E. Ambrosini, E. Martino, and P. Miccoli, “Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study,” Langenbeck's Archives of Surgery, vol. 392, no. 6, pp. 709–713, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus